Sabby Management’s bluebird bio BLUE Stock Holding History

Sabby Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,509	Closed	-$2.92M	–	307
2015 Q4	$2.92M	Buy	+3,509	New	+$3.51M	0.16%	92
2014 Q4	–	Sell	-1,897	Closed	-$1.27M	–	251
2014 Q3	$882	Buy	+1,897	New	+$875K	0.03%	158
2014 Q2	–	Sell	-7,858	Closed	-$2.52M	–	262
2014 Q1	$2.31M	Sell	7,858 -19	-0.2%	-$5.76K	0.13%	99
2013 Q4	$2.14M	Buy	+7,877	New	+$2.2M	0.14%	84

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Sabby Management's BLUE Position: Q1 2016 in Review

Sabby Management sold out of bluebird bio (BLUE) in Q1 2016, closing a stake of 3,509 shares — an estimated $2.92M sold.

Sabby Management first reported a position in BLUE in Q4 2013 and held it in 4 quarters. The position peaked at $2.92M in Q4 2015. 187 funds tracked by Wall St. Rank hold BLUE as of Q1 2016.

Sabby Management reported no remaining bluebird bio position as of Q1 2016 after selling out during the quarter.
Sabby Management sold 3,509 bluebird bio shares in Q1 2016, an estimated $2.92M.
Sabby Management first reported a position in bluebird bio in Q4 2013 and held it in 4 quarters.
Sabby Management's bluebird bio position peaked at $2.92M in Q4 2015.
187 funds tracked by Wall St. Rank held bluebird bio as of Q1 2016.

Based on Sabby Management's 13F filing for Q1 2016, filed 13 May 2016.